"Millions of Lives Are at Stake": Pressure Grows on Biden to Back WTO Waiver on Vaccine Technology

Pressure is growing on the Biden administration to support a temporary waiver on intellectual property rights for COVID-related medicines and vaccines at the World Trade Organization. India and South Africa first proposed the waiver in October, but it was blocked by the United States and other wealthy members of the WTO. Big Pharma has also come out against the proposal and has lobbied Washington to preserve its monopoly control. More than 100 countries have supported the waiver, which they say is critical to ramp up production of vaccines, treatments and diagnostic tests in the Global South. Ahead of the kickoff of two days of WTO important meetings in Geneva, we speak with Lori Wallach of Public Citizen's Global Trade Watch. The big problem is simply not enough vaccines are being produced," says Wallach. The world needs 10 to 15 billion doses to reach herd immunity, and right now all of the global production together is on track to make 6 billion doses this year."